Medical aesthetics training academy Aesthetic Intelligence is hosting a five-day advanced training programme called The Fellowship 2.0 in September 2026. Founder of Aesthetic Intelligence, consultant plastic surgeon Dr Ayad Harb, explains
Aesthetic device company Alma invited clinic owners to its Alma Academy at Kings Place, London, on June 8. The morning featured talks from aesthetic practitioners Dr Hen Ifrach, Dr Munir
Consulting company Rare. has opened its Healthcare Insights library to free access. The platform is divided into three categories; Market Insights, Market Stats and Brand Amplification. Market Insights features articles
Aesthetic practitioners Dr Mayoni Gooneratne and Dr Kate Goldie have announced the formation of the Society of Integrative Aesthetics (SIA). The association aims to explore the relationship between aesthetic outcomes,
Developing research highlights the clinical impact of glucagon-like peptide-1 receptor agonists (GLP-1RA), including their potential role in cancer risk reduction and skin ageing. A study published in Annals of Oncology
The Medicines and Healthcare products Regulatory Agency (MHRA), Advertising Standards Authority (ASA), and the General Pharmaceutical Council (GPhC) have released a warning to businesses against promoting newly licensed medicines and
The UK Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) have announced a new liaison programme. The agencies share that the roles aim to enhance day-to-day collaboration, support scientific exchange and enable
Pharmaceutical company Allergan Aesthetics, an AbbVie company, has announced Skinvive by Juvéderm has received approval from the US Food and Drug Administration (FDA) to reduce neck lines. The company shares
Artist, creative director and brand developer Russell Turner has released new publication Believe Able. According to Turner, Believe Able aims to offer healthcare and aesthetic professionals a practical framework for
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first glucagon-like peptide-1 (GLP-1) receptor agonist weight-loss tablet for use in the UK. The once-daily semaglutide tablet, marketed by